Roche vitamin C production on track

Related tags United states dollar Iso 4217 Vitamin

Swiss pharmaceuticals group Roche warned that while work at its
vitamin C plants is proceeding as planned, short to mid-term supply
of the nutrient is expected to remain tight.

Swiss pharmaceuticals group Roche says that scale-up work at its vitamin C plants is proceeding as planned.

The company has completed environmental investments at the plant at Belvidere in New Jersey, US, which is being restarted this month. Commissioning and scale-up work at the production facility at Dalry in Scotland is also proceeding as planned, but short to mid-term supply of vitamin C is expected to remain tight, said Roche.

Reporting its first quarter results last week, Roche revealed that sales at its vitamins and fine chemicals division, the world's leading supplier of vitamins and carotenoids to the feed, food, pharmaceutical and cosmetics industries, amounted to SF744 million, down by 3 per cent in local currencies or 14 per cent in Swiss francs.

On a comparable basis local-currency sales remained nearly stable, decreasing slightly by 0.7 per cent. The division posted volume gains for the quarter, despite the continuing impact of a difficult economic climate, according to the company.

The sale of Roche Vitamins​ to Netherlands-based DSM is still subject to approval by antitrust authorities, which is expected this spring. The division's results will be included in Roche's consolidated accounts until the transaction is closed.

Despite the weaker sales in the vitamins unit, sales growth at the company's core businesses was 15 per cent in local currencies (3 per cent in Swiss francs) leading to combined sales of SF6.7 billion from the core businesses in the first three months of 2003.

Related topics Formulation & Science Skin Care

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast